Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.
Authors: Caulfield JI; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA., Aizenbud L; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA., Perdigoto AL; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Meffre E; Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA., Jilaveanu L; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA., Michalek DA; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA., Rich SS; Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA., Aizenbud Y; Department of Mathematics, Program in Applied Mathematics, Yale University, New Haven, Connecticut, New Haven, Connecticut, USA., Adeniran A; Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Herold KC; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Austin MR; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA., Kluger H; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Mar; Vol. 11 (3).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2022-006570